Therapeutic Nuclear Medicines Market Revenue 2024 to 2034
Therapeutic Nuclear Medicines Market Revenue 2024 to 2034
The Therapeutic Nuclear Medicines Market is projected to expand from USD 29.62 Bn in 2024 to USD 48.94 Bn by 2034, at a CAGR of 5.1%. Growth is driven by rising adoption of targeted radiotherapies, increasing prevalence of cancer, and advancements in nuclear medicine technologies worldwide.
Report ID: 10334
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 29.62 Bn
Forecast Year,
USD 48.94 Bn
CAGR, 2025 -
5.15%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Therapeutic Nuclear Medicines Market Size Analysis
Therapeutic Nuclear Medicines Market Size By Therapy & Class 2024 to 2034 (USD )
| Therapy & Class | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Small Molecules | 9.48 | 10.05 | 10.54 | 11.12 | 11.61 | 12.15 | 12.71 | 13.32 | 14.02 | 14.74 | 15.54 |
| Biologics | 10.07 | 10.60 | 11.21 | 11.72 | 12.39 | 13.10 | 13.82 | 14.57 | 15.34 | 16.09 | 16.85 |
| Advanced Therapies | 5.33 | 5.56 | 5.85 | 6.14 | 6.47 | 6.83 | 7.17 | 7.60 | 7.97 | 8.43 | 8.88 |
| Others | 4.74 | 4.93 | 5.15 | 5.45 | 5.74 | 5.99 | 6.32 | 6.60 | 6.94 | 7.29 | 7.67 |
Therapeutic Nuclear Medicines Market Size By Indication 2024 to 2034 (USD )
| Indication | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncology | 10.66 | 11.17 | 11.72 | 12.31 | 13.01 | 13.66 | 14.37 | 15.14 | 15.91 | 16.72 | 17.60 |
| Cardio-Metabolic | 5.33 | 5.57 | 5.85 | 6.17 | 6.46 | 6.82 | 7.11 | 7.43 | 7.76 | 8.15 | 8.54 |
| Infectious | 4.74 | 5.00 | 5.28 | 5.54 | 5.85 | 6.15 | 6.52 | 6.89 | 7.30 | 7.62 | 8.00 |
| CNS | 4.15 | 4.36 | 4.60 | 4.82 | 5.04 | 5.32 | 5.59 | 5.89 | 6.20 | 6.55 | 6.92 |
| Others | 4.74 | 5.03 | 5.29 | 5.59 | 5.84 | 6.12 | 6.44 | 6.74 | 7.09 | 7.50 | 7.88 |
Therapeutic Nuclear Medicines Market Size By Distribution 2024 to 2034 (USD )
| Distribution | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacy | 13.03 | 13.68 | 14.43 | 15.14 | 16.02 | 16.81 | 17.68 | 18.63 | 19.80 | 20.89 | 22.00 |
| Retail Pharmacy | 10.66 | 11.23 | 11.75 | 12.41 | 12.97 | 13.70 | 14.38 | 15.13 | 15.71 | 16.50 | 17.35 |
| Online/Other | 5.92 | 6.24 | 6.57 | 6.89 | 7.21 | 7.56 | 7.97 | 8.34 | 8.75 | 9.15 | 9.59 |
Therapeutic Nuclear Medicines Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 11.85 | 12.54 | 13.13 | 13.83 | 14.59 | 15.34 | 16.12 | 16.87 | 17.68 | 18.55 | 19.61 |
| Europe | 8.29 | 8.65 | 9.18 | 9.63 | 10.10 | 10.66 | 11.20 | 11.84 | 12.50 | 13.19 | 13.80 |
| Asia Pacific | 7.11 | 7.47 | 7.82 | 8.22 | 8.61 | 9.02 | 9.53 | 10.04 | 10.56 | 11.12 | 11.65 |
| Latin America | 1.18 | 1.24 | 1.30 | 1.38 | 1.46 | 1.53 | 1.60 | 1.69 | 1.78 | 1.86 | 1.94 |
| Middle East & Africa | 1.18 | 1.24 | 1.31 | 1.38 | 1.45 | 1.51 | 1.58 | 1.66 | 1.74 | 1.83 | 1.93 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
